# Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

> **NCT05905120** · PHASE1 · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 6 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Toludivenlafaxine hydrochloride sustained-release tablets

## Key facts

- **NCT ID:** NCT05905120
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-02
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-26
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05905120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05905120, "Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05905120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*